Market Tracker

09/19 6:35pm ET

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

69.85
Data as of Sep 19
 +0.25 / +0.36%
Today’s Change
55.04
Today|||52-Week Range
84.25
-0.71%
Year-to-Date

Today’s Trading

Previous close69.60
Today’s open69.75
Day’s range68.94 - 69.96
Volume1,761,113
Average volume (3 months)1,049,121
Market cap$10.3B
Dividend yield--
Data as of 3:59pm ET, 09/19/2014

Growth & Valuation

Earnings growth (last year)-34.74%
Earnings growth (this year)+2.05%
Earnings growth (next 5 years)+12.50%
Revenue growth (last year)+10.82%
P/E ratioNM
Price/Sales17.67
Price/Book7.47

Competitors

 Today’s
change
Today’s
% change
ENDPEndo International P...+0.76+1.14%
MNKMallinckrodt Plc+1.12+1.28%
SLXPSalix Pharmaceutical...+4.46+2.79%
JAZZJazz Pharmaceuticals...+0.41+0.25%
Data as of 4:02pm ET, 09/19/2014

Financials

Next reporting dateOctober 23, 2014
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$548.4M
Annual profit (last year)-$176.4M
Net profit margin-32.15%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Daniel K. Spiegelman
Corporate headquarters
San Rafael, California

Forecasts